national drug policy
TRANSCRIPT
![Page 1: National drug policy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/58757b601a28ab78498b5fc3/html5/thumbnails/1.jpg)
NATIONAL DRUG POLICY
DHANYA.O.G2010-09-114
![Page 2: National drug policy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/58757b601a28ab78498b5fc3/html5/thumbnails/2.jpg)
INTRODUCTION
First edition of NDP was adopted and published in 1990 to address the inadequacies in drug availability, supply and distribution.
The NDP is a documentation of govt’s commitment on drug issues of the country
![Page 3: National drug policy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/58757b601a28ab78498b5fc3/html5/thumbnails/3.jpg)
BACKGROUND TO THE NDP
Ineffective system of drug administration and control Inadequate funding of drug supply and control
activities High dependence on foreign sources for finished
drug products Inadequate facilities for storage, transportation and
distribution of drugs Poor selection and procurement practices Poor performance of drug suppliers
![Page 4: National drug policy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/58757b601a28ab78498b5fc3/html5/thumbnails/4.jpg)
Background cont’d
Involvement of unqualified people on procurement and distribution and sale of drugs
Poor capacity utilisation of the local drug Manufacturing companies
Poor R&D activities, out comes and poor input into pharmaceutical manufacturing
etc.
![Page 5: National drug policy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/58757b601a28ab78498b5fc3/html5/thumbnails/5.jpg)
GOALS & OBJECTIVES
To make available at all times at adequate level , affordable rate , good quality and in safely manner
To ensure rational use of such drugs To stimulate increased local production of
essential drugs
![Page 6: National drug policy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/58757b601a28ab78498b5fc3/html5/thumbnails/6.jpg)
GOALS & OBJs CONT’D
NDP is to: Ensure efficient & effective drug mgt. in the
system. Strengthen Administrative, Legislative &
Regulatory controls of importation, procurement, storage, distribution, supply, sale and use of drugs.
![Page 7: National drug policy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/58757b601a28ab78498b5fc3/html5/thumbnails/7.jpg)
Goals cont’
To promote pharmaceutical research and development of raw materials for production ,
compounding & formulation of pharmaceutical products.
Promote research on herbal remedies and integrate those found to be safe and efficacious into the health care system.
![Page 8: National drug policy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/58757b601a28ab78498b5fc3/html5/thumbnails/8.jpg)
HOW POLICY IS OPERATIONALISED BY STAKEHOLDERS:
FEDERAL MINISTRY OF HEALTH (FMOH) has the secretariat of the NDP
Role includes: Dissemination , Dev. of necessary guidelines, Training,
capacity building, M&E.National Agency for Food and Drug Administration and
Control (NAFDAC), PCN(Primary Care Network ) ensure regulatory aspect eg. Inspection , Registration etc.
to ensure good quality and efficacy of drugs as well as good pharmacy practice.
![Page 9: National drug policy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/58757b601a28ab78498b5fc3/html5/thumbnails/9.jpg)
National Institute for Pharmaceutical Research and Development ( NIPRD )-deals with the R&D aspect
![Page 10: National drug policy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/58757b601a28ab78498b5fc3/html5/thumbnails/10.jpg)
SUPPLY CHAIN STRATEGIES IN THE NDP: TARGETS OF THE NDP
Rational Drug Selection Proper Quantification of Drug needs at all
levels of health care delivery. Good & Effective procurement Practices. Assurance of quality of drugs at all levels. Appropriate warehousing &storage facilities. Proper costing.
![Page 11: National drug policy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/58757b601a28ab78498b5fc3/html5/thumbnails/11.jpg)
SUPPLY CHAIN STRATEGIES IN NDP. CONT’
Effective Distribution Of drugs. Promotion of Local drug manufacturing. Appropriate legislation Product registration Research & Development Human resource development Inventory Control
![Page 12: National drug policy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/58757b601a28ab78498b5fc3/html5/thumbnails/12.jpg)
SUPPLY CHAIN STRATEGIES IN THE NDP. Cont’
Enabling environment International cooperation & Donor
collaboration. Proper accountability Rational use of Drugs Monitoring & Evaluation
![Page 13: National drug policy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/58757b601a28ab78498b5fc3/html5/thumbnails/13.jpg)
SUPPLY CHAIN STRATEGIES IN THE NDP. Cont’
Product selection
Revised Essential Drugs List (EDL) listed by generic or International Non-Proprietary Name (INN)
EDL updated every 4 yrs by EDL Review Committee EDL used for procurement prescribing & dispensing EDL used for production of STGs(standard treatment
guidelines) and National Drug Formulary
![Page 14: National drug policy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/58757b601a28ab78498b5fc3/html5/thumbnails/14.jpg)
Quantification & Procurement Criteria
Quantification by the Pharmacy Department (i.e. the Food & Drug Services Dept of the Federal Min of Health)
Open & transparent by competitive tender with the advice of the Pharm Dept. Giving preference to local industry
Ensure drugs supplied are of good quality
Bulk purchase to ensure low prices.
Quality assessment before distribution
![Page 15: National drug policy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/58757b601a28ab78498b5fc3/html5/thumbnails/15.jpg)
Drug Warehousing and Storage objectives:
Ensure stock security Maintenance of quality of drugs throughout
shelf life Suitably located, constructed and equipped
storage facilities at every level of drug distribution system.
Expired or deteriorated stock officially destroyed within 6 months
![Page 16: National drug policy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/58757b601a28ab78498b5fc3/html5/thumbnails/16.jpg)
Drug Warehousing objs cont’d
Regular checks on drugs Appropriate cool and cold storage facilities in
the medical stores Professional skill of the Pharmacist is
required for efficient operation of a drug store
![Page 17: National drug policy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/58757b601a28ab78498b5fc3/html5/thumbnails/17.jpg)
Inventory Control
Central computerized inventory control systems in the central stores at all levels
Computerization of inventory control systems in hospital pharmacies and clinics
![Page 18: National drug policy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/58757b601a28ab78498b5fc3/html5/thumbnails/18.jpg)
Distribution Measures
Drug distribution, supply, sale and dispensing shall be under the control of pharmacists
All drugs purchased or donated to governments channeled through CMS(case management committee)
Adequate security provided for storage areas and particularly for narcotic drugs
Drug distribution channel shall be Manufactures/ Importers – Wholesalers – Retailers.
![Page 19: National drug policy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/58757b601a28ab78498b5fc3/html5/thumbnails/19.jpg)
Rational Product Use
Up-to-date STGs and National Formulary Prescribing by INN or generic names Drug and Therapeutic Committees
established in all tertiary and secondary health care institutions
Establishment of diagnostic services appropriate to the level of care.
![Page 20: National drug policy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/58757b601a28ab78498b5fc3/html5/thumbnails/20.jpg)
Quality Assurance
Establishment of QC labs in strategic locatn’ Universities with appropriate facility to join in
assessment of drug quality. Appropriate packaging by manufacturers to
ensure quality and stability of products.
![Page 21: National drug policy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/58757b601a28ab78498b5fc3/html5/thumbnails/21.jpg)
Enabling Environment
Continue to strengthen NAFDAC,PCN for enhancement of regulatory environment
Introduction of adverse drug reaction reporting system (Pharmacovigilance) etc.
![Page 22: National drug policy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/58757b601a28ab78498b5fc3/html5/thumbnails/22.jpg)
International Cooperation & Donor Collaboration
Establishment and maintenance of appropriate channels of communication between drug regulatory and law enforcement authorities
Use of diplomatic channels for exchange of information on sub-standard and counterfeit drugs in international commerce
Promoting the training of personnel and human resource development.
![Page 23: National drug policy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/58757b601a28ab78498b5fc3/html5/thumbnails/23.jpg)
Monitoring, Evaluation & Drug Mgt Information Systems
Setting up of a National Drug Policy Monitoring and Evaluation Unit in the FMOH
Institutionalising of drug management information systems as a basis for deriving drug management and other relevant information for taking decisions
Monitoring of effect of TRIPS on access to Essential Medicines.
![Page 24: National drug policy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/58757b601a28ab78498b5fc3/html5/thumbnails/24.jpg)
THE END
THANK YOU